Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Nandabalan Krishnan
Director at BioXcel Therapeutics. Filing since 29 Nov 2018.
CIK 0001733387
Company
Date
Role
Action
Shares
Amount
Of holding
BTAI
BioXcel Therapeutics, Inc.
6 Apr 2023
Director
Sold on a plan
60,000
$1.04M
100%
BTAI
BioXcel Therapeutics, Inc.
5 Jan 2023
Director
Sold, plan not stated
25,889
$578.33K
100%
BTAI
BioXcel Therapeutics, Inc.
4 Jan 2023
Director
Sold, plan not stated
34,111
$742.55K
100%
BTAI
BioXcel Therapeutics, Inc.
11 Nov 2022
Director
Sold, plan not stated
32,550
$488.25K
100%
BTAI
BioXcel Therapeutics, Inc.
10 Nov 2022
Director
Sold, plan not stated
27,450
$411.75K
100%
BTAI
BioXcel Therapeutics, Inc.
25 Jun 2021
Director
Sold, plan not stated
473,250
$14.59M
5.2%
BTAI
BioXcel Therapeutics, Inc.
29 Nov 2018
Director
Bought
1,000
$4.92K
opened
7 decisions on file.
